Edward Graves
Publications
- Development of a micro-computed tomography-based image-guided conformal radiotherapy system for small animals. Int J Radiat Oncol Biol Phys. 2010; (1): 297-305
- Hypoxia in models of lung cancer: implications for targeted therapeutics. Clin Cancer Res. 2010; (19): 4843-52
- RT_Image: an open-source tool for investigating PET in radiation oncology. Technol Cancer Res Treat. 2007; (2): 111-21
- Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013
- Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal. J Nucl Med. 2013; (1): 27-32
- Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer. 2012; (3): 219-24
- Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer. Clin Lung Cancer. 2012; (1): 52-8
- Monte Carlo model of the scanning beam digital x-ray (SBDX) source. Phys Med Biol. 2012; (22): 7381-94
- Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Am J Clin Oncol. 2012; (4): 334-9
- Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer. Int J Radiat Oncol Biol Phys. 2012; (2): 471-7
- Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Res. 2012; (15): 3725-34
- Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer. Clin Cancer Res. 2012; (6): 1798-807
- Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes. Int J Radiat Oncol Biol Phys. 2012; (5): 1521-7
- SU-E-J-177: Characterization of the Effect of ''Lung Detail'' CT Reconstruction Algorithm on Radiation Therapy Dose Calculation. Med Phys. 2012; (6): 3693
- The potential for Cerenkov luminescence imaging of alpha-emitting radionuclides. Phys Med Biol. 2012; (3): 771-83
- Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012; (5): 1514-20
- Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity. Radiother Oncol. 2011; (3): 356-61
- Facilitating multimodal preclinical imaging studies in mice by using an immobilization bed. Comp Med. 2011; (6): 499-504
- Molecular Imaging of Hypoxia: Strategies for Probe Design and Application. Curr Org Synth. 2011; (4): 593-603
- Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011; (2): 514-21
- Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med. 2011; (94): 94ra70
- The importance of tissue segmentation for dose calculations for kilovoltage radiation therapy. Med Phys. 2011; (6): 3039-49
- Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011; (5): 920-6
- 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2010; (5): 1420-5
- Investigation of the effects of treatment planning variables in small animal radiotherapy dose distributions. Med Phys. 2010; (2): 590-9
- The tumor microenvironment in non-small-cell lung cancer. Semin Radiat Oncol. 2010; (3): 156-63
- A bone composition model for Monte Carlo x-ray transport simulations. Med Phys. 2009; (3): 1008-18
- Commissioning of a novel microCT/RT system for small animal conformal radiotherapy. Phys Med Biol. 2009; (12): 3727-40
- Kilovoltage beam Monte Carlo dose calculations in submillimeter voxels for small animal radiotherapy. Med Phys. 2009; (11): 4991-9
- Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009; (5): 1335-41
- Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment. Am J Clin Oncol. 2009; (4): 364-8
- Pharmacologically increased tumor hypoxia can be measured by 18F-Fluoroazomycin arabinoside positron emission tomography and enhances tumor response to hypoxic cytotoxin PR-104. Clin Cancer Res. 2009; (23): 7170-4
- The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res. 2009; (3): 775-84
- In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2008; (4): 1151-7
- Oxygen sensitivity of reporter genes: implications for preclinical imaging of tumor hypoxia. Mol Imaging. 2007 Jul-Aug; (4): 219-28
- Design and evaluation of a variable aperture collimator for conformal radiotherapy of small animals using a microCT scanner. Med Phys. 2007; (11): 4359-67
- Imaging tumoral hypoxia: oxygen concentrations and beyond. Oncology (Williston Park). 2007; (3): 368-76; discussion 377-8, 384
- Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007; (2): 328-33
- Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog. J Nucl Med. 2007; (6): 987-94
- Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed. 2006; (4): 463-75
- Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography. J Biomed Opt. 2005 Jul-Aug; (4): 44019
- Fluorescence molecular imaging of small animal tumor models. Curr Mol Med. 2004; (4): 419-30
- Singular-value analysis and optimization of experimental parameters in fluorescence molecular tomography. J Opt Soc Am A Opt Image Sci Vis. 2004; (2): 231-41
- Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A. 2004; (33): 12294-9
- A submillimeter resolution fluorescence molecular imaging system for small animal imaging. Med Phys. 2003; (5): 901-11
- In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res. 2003; (20): 6838-46
- In vivo tomographic imaging of near-infrared fluorescent probes. Mol Imaging. 2002 Apr-Jun; (2): 82-8
- Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg. 2002; (4): 794-802
- In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging. 2002; (4): 464-76
- Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys. 2002; (5): 1254-64
- MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys. 2001; (4): 915-28
- Registration of magnetic resonance spectroscopic imaging to computed tomography for radiotherapy treatment planning. Med Phys. 2001; (12): 2489-96
- Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol. 2001; (4): 613-24
- A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery. 2000; (2): 319-26; discussion 326-8
- Gamma Knife Radiosurgery for Primary Brain Tumors LINAC and Gamma Knife Radiosurgery (Germano, I.M., ed.). 2000: 189-202
- CNN-Based Models for Color Vision and Visual Illusions IEEE Transactions on Circuits and Systems I: Fundamental Theory and Applications. 1999: 229-238
Help
Trial Administration